Reumatoloxía

2013

1. A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis

   Clinical and Experimental Rheumatology, Vol. 31, Núm. SUPPL.75

2. A full new enthusiastic team

   Rheumatology International

3. A new fast method for peptide biomarker discovery in human serum by mass spectrometry

   Proteómica: revista de la Sociedad Española de Proteómica, Núm. 9, pp. 52-52

4. A quantitative proteomic approach for the discovery of characteristic biomarkers in osteoarthritis cartilage

   Proteómica: revista de la Sociedad Española de Proteómica, Núm. 9, pp. 83-83

5. Achievements and challenges of proteomics in the study of rheumatoid arthritis

   Current Topics in Medicinal Chemistry, Vol. 13, Núm. 6, pp. 732-742

6. Actualización del uso de los glucocorticoides en la artritis reumatoide

   Reumatologia Clinica

7. Adipokines, molecular players at the crossroad between inflammation and oxidative stress: Role in arthropathies

   Studies on Arthritis and Joint Disorders (Springer New York), pp. 67-88

8. Adipokines: Novel players in rheumatic diseases

   Discovery Medicine, Vol. 15, Núm. 81, pp. 73-83

9. Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

   Clinical and Experimental Rheumatology, Vol. 31, Núm. 3, pp. 365-371

10. An assessment of the indirect high intensity ultrasonic assisted cleavage of complex proteomes with immobilized trypsin.

    Talanta, Vol. 106, pp. 163-168

11. Antitumour necrosis factor-α therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients

    Annals of the Rheumatic Diseases

12. Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 4, pp. 532-537

13. Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 5, pp. 749-755

14. Biologic Therapy In Refractory Uveitis Of Behcet's Syndrome: Switching and Dose Modification. Multicenter Study Of 124 Patients

    ARTHRITIS AND RHEUMATISM

15. Biologic Therapy In Refractory Uveitis Of Sarcoidosis. Multicenter Study Of 16 Patients

    ARTHRITIS AND RHEUMATISM

16. Biopsy-proven giant cell arteritis patients with coronary artery disease have increased risk of aortic aneurysmal disease and arterial thrombosis

    Clinical and Experimental Rheumatology

17. Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: Systematic literature review and meta-analysis informing a consensus statement

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 583-589

18. CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in spanish rheumatoid arthritis patients

    DNA and Cell Biology, Vol. 32, Núm. 1, pp. 28-33

19. Chromosome 16 consortium: Current developments on the characterization of the proteins encoded by the chromosome 16”

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 9, pp. 112-112

20. Chromosome 16. Transcriptomic and sg proteomic profiling of lymphocyte t jurkat cells, mcf-7 epithelial cells and ccd18 fibroblasts

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 9, pp. 113-113